newsfilter
← Latest News
PR Newswire·

Aeglea BioTherapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Aeglea BioTherapeutics, Inc. ("Aeglea" or the "Company") (NASDAQ:AGLE), a biotechnology company advancing a pipeline of antibody therapeutics with...